Biotech

Artificial Intelligence in the Biotechnology - 5 Key Trends

Artificial Intelligence in the Biotechnology – 5 Key Trends

Artificial Intelligence in the Biotechnology – 5 Key Trends 1440 810 Xcelpros Team

At a Glance

  • The biotech industry is witnessing unprecedented demand on many fronts. Companies are looking to invest in fast-paced innovation, systematic storage of massive research data, analysis of humongous databases, and meticulous management of the business processes. AI-enabled applications play a crucial role in meeting these demands.
  • Machine learning, robotics, informatics, and AI branches can help in expanding the horizons of the biotechnology industry and move towards newer possibilities.

AI-led Transformation of the Biotech Industry and Its Positive Effects

The Biotechnology industry is currently relying heavily on storage, filtration, analysis, and the exchange of data. Massive databases are maintained by biotechnology companies and various health organizations worldwide. Drug manufacturing, chemical analysis of different compounds, sequencing of RNA and DNA, enzyme studies, and other similar biological processes require the strong support of computerized tools and applications to gain pace and reduce manual errors.

Today, the world is witnessing an unprecedented health emergency in terms of the Coronavirus pandemic. Economies are collapsing, countries are under lockdown, and all hopes are pinned on the biotechnology industry to come up with a safe, effective vaccine in the shortest possible time frame. The use of Artificial Intelligence in biotechnology and related applications play a crucial role in managing biological processes, boosting drug production, handling supply chains, and taking care of the pool of data for this industry.

Increased and better predictability for both structured and unstructured data helps companies in planning their operations accordingly for enhanced productivity and a faster pace of work.

Figure 1Applications of Artificial Intelligence in Different Fields of Biotechnology

Leading biotech companies are investing in advanced AI tools to:

  • Analyze research data
  • Accelerate vaccine development
  • Classify the target market and demographic
  • Identify the right ingredient to produce the vaccine

86%of current or planned AI spending is in customer-oriented areas, with marketing and sales leading the pack

$1.2 TNestimated additional revenue/ shifting revenue driven by AI in three years

While there are still many unknowns when it comes to a successful coronavirus vaccine, this US biotech firm has applied artificial intelligence to accelerate the process of vaccine development.

The biotechnology sector will leverage artificial intelligence and its related applications with vigor in the coming years. According to an article for Medium by Melanie Matheu, Ph.D., the next generation of therapeutics entering drug pipelines will contain targets selected by AI screening, likely improving the 86% clinical trial failure rates for small molecules.

The biotechnology industry has various sub-sectors ranging from human life sciences, food industry, agricultural biotechnology, animal biotechnology, and industrial applications. These branches can all leverage the advancements seen in artificial intelligence and machine learning related applications developed in the past decade, including five key AI trends that will transform the biotechnology industry, listed below.

The Application of AI is Shifting More Towards Knowledge Workers

79%agree AI and related technologies are having a transformational impact on workflows and tools for knowledge workers

80% say that placing powerful AI-fueled application in the hands of knowledge workers is critical to productivity and performance

84% agree AI streamlines processes, freeing knowledge workers for move creative, intuitive and laterally thinking activities

Source: Microsoft

Here are 5 key AI trends that will transform the biotechnology industry

01Boosting Innovations: From Lab to the Market

The past decade has witnessed the need for fast-tracked innovation, production and deployment of drugs, industrial chemicals, food-grade chemicals, and other biochemistry-related raw material. AI in Biotech plays a crucial role in boosting innovation not only in the laboratories but also throughout the lifecycle of a drug or chemical compound (right to the point where it reaches the market). Based on the target market, AI-based tools and applications help in developing the structure of molecules. Machine learning, a subset of artificial intelligence, helps in calculating permutations and combinations of various chemicals to know the right combination, without having to perform the experiments in the lab through manual processes. The use of artificial intelligence in biotechnology is bringing innovations that can help in predictive analysis to forecast the demand for a particular drug or a chemical in the market. AI in Biotech can also help in managing the smart distribution of the raw material required by the biotechnology industry through the use of cloud computing.

Figure 2Functionalities of AI in Biotech Industry

02Open Source AI Platforms: Faster Data Analysis

Scientists across the globe are looking at AI programs that can take over the tedious nature of data maintenance and data analysis. Tasks like gene editing, enzyme compositions, chemical studies, and such crucial informatics are analyzed systematically for faster and more accurate results. Open-source AI programs such as CRISPR libraries and H2O.ai are playing an essential role on this front by relieving lab assistants of repetitive tasks like data entries and analysis. By eliminating manual functions for healthcare providers and scientists, they can better focus their efforts on innovation-driven processes and it will be possible with the use of artificial intelligence in biotechnology.

03Pushing the Boundaries of Agricultural Biotechnology: Increasing Quality and Quantity

Biotechnology plays a crucial role in genetically modifying plants to develop more and better crops. AI-based tools become essential to this process of genetic modification to study the features of the crop, to note down and compare qualities, and to forecast plausible yield. Apart from these tools, robotics, an arm of artificial intelligence, is being used by the agricultural biotechnology industry for packaging, harvesting, and other essential tasks. AI in biotech also helps in planning the upcoming patterns in the movement of material by combining weather forecasts, data on the nature of farmlands, and the availability of seeds, manure, and pesticides.

04Discovery of New Drugs and Vaccines: Shrinking the Timeline

In a globalized world, newer diseases have a fast way to spread across continents. Thus, the biotechnology industry is at a race against time to develop newer drugs and vaccines to be able to contain such diseases. Artificial intelligence and machine learning are vital in speeding up the process of recognizing the right molecules, helping in synthesizing them in the labs, data analysis for efficacy, and it supplies to the market. Operations, which would usually take 5-10 years, have now been shrunk to 2-3 years with the use of artificial intelligence in biotechnology.

Figure 3Subsets of Artificial Intelligence in Biotechnology

05Facilitating Global Connect: Sharing Biotechnology Developments Worldwide

AI platforms are resourceful in letting scientists across the globe have access to imperial data regarding newer drugs and other industrial developments. Many machine learning tools are assisting scientists in decoding data and understanding patterns of a particular disease in a far-away country and utilizing it to build analytical models for their geography. The accuracy of scientific models has increased by several folds, after the introduction of AI in Biotech.

While these are the key trends, AI and related tools are helping in transforming the biotechnology industry in many ways. Coming times will see the use of artificial intelligence in biotechnology for the betterment of humankind by the progress it facilitates in the fields of biosciences and technologies.

The power of integration of Microsoft’s AI with Microsoft Dynamics 365 helps biotech companies get over the industry’s pressing challenges. Hindrances such as resource management, stringent regulations, quality management, etc., and establishes seamless workflow by ensuring unified data sharing, visibility, and connectivity across diverse channels and operations so that teams better communicate.

This collaboration with the use of artificial intelligence in biotechnology helps your company to

  • Achieve regulatory compliance
  • Gain visibility into your supply chain management
  • Track and control your inventory with accuracy, and
  • Integrate industry best practices for corrective and preventive action

Finally, the digital transformation achieved with the Full Microsoft Suite gives you data in real-time to make smart and actionable business decisions to spur company growth.

Key Takeaways

  • The biotechnology industry has progressed significantly with the application of AI and related computerized tools.
  • Be it medical, industrial or agricultural biotechnology, AI, machine learning, and robotics play critical roles in pushing the boundaries of possibilities in these fields.

Using our years of industry experience in the biotech, life sciences, and pharmaceutical industries, we suggest and help our customers with the best ways to reduce costs and mitigate implementation risks. We work with you throughout the implementation, so that you can quickly identify, address, and record any production, shipping or quality control risks, events, and complaints. A personalized, flexible D365 dashboard equips your teams to trigger a hold on products throughout the supply chain autonomously, launch nonconformance reports, send notifications to managers when test results hit a certain threshold or when a specific research milestone deadline is compromised.

About XcelPros

XcelPros is a Chicago-based company and delivers transformation through technology. We offer business and technology solutions with deep industry experience in Chemical, Pharma, Life Sciences (including Medical Devices, Bio-Medical & Biotech), Insurance, Discrete Manufacturing, Process Manufacturing, Distribution and Food & Beverage.

XcelPros is a Microsoft Gold Partner, Direct Cloud Solutions Provider (CSP) and a Systems Integrator (SI) offering software licensing, implementation and consulting services for Microsoft Dynamics 365, CRM, Microsoft Dynamics AX, Business Intelligence & Analytics (Power BI), SharePoint, Office 365 and Azure (Cloud, IOT, Microsoft Flow amongst many others).

Our mission is to provide integrated technology solutions that amplify impact and empower our customer’s businesses. We believe technology is the key enabler of exponential growth for us and our customers.

Contact XcelPros today to transform your business.

Call us toll-free – 1.855.411.0585 (or) visit www.xcelpros.com

Current biotechnology issues

Top Concerns of Biotechnology Industry Current Issues

Top Concerns of Biotechnology Industry Current Issues 1920 1080 shahid.anis

At a Glance

  • The world has turned its hopes towards biotech companies to reduce the spread and impact of the Covid-19 pandemic.
  • The biotech industry is working continuously towards fortifying healthcare systems, enabling serosurveillance to gauge the spread of disease in a community and to aid in the development of a vaccine.
  • With governments across the globe funding research and production costs to enable biotech companies to win this battle against time, there are various operational, technological, and workforce concerns that these companies face that need to be addressed with strategic maneuvering from the apex.

Introduction

The Biotech and Life Sciences industry is one of the most sought after sectors this year in conjunction with the pharmaceutical industry as a solution to the current Covid-19 pandemic. Health experts across the globe have agreed that highly effective treatments, including the development of a vaccine, would be needed to reduce and eventually stop the spread of novel coronavirus, allowing cultures around the world to get back to normal activity. While some countries have fared better than others in handling the Covid-19 health crisis, there are still looming fears of new waves. Current Biotechnology issues are expected to normalize with an effective antidote or vaccine.

While the biotech industry sprung into action to begin developing a solution almost immediately, there’s still a long way to go. Challenges faced by biotechnology have been as real as the crisis itself. While the biotech and life sciences industry has a primary role in addressing pandemics like that of COVID-19, it’s not immune to economic downturns, supply chain disruptions, workforce shortage, or any other challenges.

Below are some of the pain points that the Biotech and Life Sciences industry are facing:

01.Roadblocks and Hurdles

All over the world, various biopharma companies, both privately and through government-funded efforts, are performing clinical trials for different potential vaccines and drugs. In 63 days after the genome sequence of the novel coronavirus was shared with the world, USA’s Moderna Biotech Inc. had developed its mRNA candidate to battle the pandemic. Being able to move at a pace never seen before requires immense talent, robust AI-enabled software setup to perform bioinformatics processes, and exceptional R&D infrastructure.

The journey from vaccine development to approval and administration on a global scale is wrought with numerous additional steps and hurdles, requiring mobilization of assets and task forces, recruitment of volunteers, conducting clinical trials, collation, and analysis of humongous amounts of data, smoothly operating supply chains, enormous monetary investments, and a well-equipped production and distribution infrastructure.

02.Collateral Delays

The spread of the coronavirus pandemic brought most of the world to a screeching halt, with many businesses having been forced to close. A result of this is disruptions to major clinical trials and research work on drugs and vaccines for other life-threatening diseases like cancer, HIV, autoimmune diseases, etc. These are collateral delays, and the biotech industry is now challenged with not ignoring existing health issues while still focusing on developing a solution for the ongoing pandemic.

03.Global Distribution

Health experts and top executives at significant biotech companies agree that even if we succeed in making an effective vaccine for Covid-19, there would be a need for immense strategic and operational changes in the current global and local supply chains to ensure that it’s produced and distributed to everyone around the world. With disruptions to most supply chains, only adding to challenges faced by the Biotechnology industry, it will be interesting to see how these organizations address these issues.

Figure 1Covid-19 Vaccine Development in Phases: The Role of Biotech and Pharma

04.ROI

A global health crisis of this scale requires a humanitarian approach to ensuring treatment is available to all. This is why most pharmaceutical and biotech companies have agreed that the first or even second batches of any drugs or vaccines they produce(should they prove to be valid) will be distributed at non-profitable rates. We shouldn’t, however, neglect the current biotechnology issues who are investing millions of dollars in rising to the occasion. These organizations will need a blueprint for steady business growth and monetary returns in the post-COVID era.

05.Remote Solutions

Now more than ever, biotech companies need highly skilled and experienced scientists, health experts, and paramedical personnel who can make this journey towards vaccine development smooth. With most businesses still not fully operational to support new workplace requirements, more remote access solutions will have to be developed and embraced to keep operations moving forward.

Role of Microsoft Dynamics 365 Supply Chain Tools in Biotech Companies

We have spoken about some ongoing challenges faced by the biotechnology industry in the war against Covid-19. It is important to note that current biotechnology issues are handled with strategic realignment and robust Enterprise Resource Planning tools. An ERP tool such as Microsoft Dynamics 365 Supply Chain enables biotech companies of all sizes to optimize their supply chains, mitigate costs on manual labor, avoid redundant efforts, automate billing cycles, and other enterprise-level processes.

Key Takeaways

These are challenging times for organizations in the Biotech and Life Sciences industry. They now, more than any other sector, continue to work at unprecedented speeds to help the world end this global crisis. Billions of lives are at stake, waiting anxiously for a solution to the ongoing pandemic. There are many challenges that the biotech sector needs to address from disrupted supply chains to the need for multi-layered coordination for clinical trials. With strategic intervention by strong leadership and the use of modern robust tools, these challenges and more, can all be overcome.

About XcelPros

XcelPros is a Chicago-based company and delivers transformation through technology. We offer business and technology solutions with deep industry experience in Chemical, Pharma, Life Sciences (including Medical Devices, Bio-Medical & Biotech), Insurance, Discrete Manufacturing, Process Manufacturing, Distribution and Food & Beverage.

XcelPros is a Microsoft Gold Partner, Direct Cloud Solutions Provider (CSP) and a Systems Integrator (SI) offering software licensing, implementation and consulting services for Microsoft Dynamics 365, CRM, Microsoft Dynamics AX, Business Intelligence & Analytics (Power BI), SharePoint, Office 365 and Azure (Cloud, IOT, Microsoft Flow amongst many others).

Our mission is to provide integrated technology solutions that amplify impact and empower our customer’s businesses. We believe technology is the key enabler of exponential growth for us and our customers.

Contact XcelPros today to transform your business.

Call us toll-free – 1.855.411.0585 (or) visit www.xcelpros.com

CRO Strategic Partnerships

How life sciences cros are changing to strategic partners?: the covid-19 effect

How life sciences cros are changing to strategic partners?: the covid-19 effect 1500 1000 Xcelpros Team

At a Glance

  • The biotechnology and life sciences industry is at a cusp of major changes due to COVID-19. There is a lot of fluidity built up due to the pandemic and a huge dependency on government rules, FDA regulations, intricate drug production, and overall research and development at this time.
  • These firms are looking for CROs who can take the role of strategic partners that can manage their life sciences research & development. The preference of CROs has already shifted from traditional to technologically adaption that can handle the rapid pace needed due to the existing COVID-19 emergency.
  • The call for innovation and increased collaboration amongst the CROs have led to the onset of a new, evolved era of project management that is more comprehensive improving customer engagement and experience.

The Role of a Contract Research Organization

Project management is considered to be the backbone of any Contract Research Organization be it for biopharmaceutical development, commercialization, preclinical research, clinical research, clinical trial management, or pharmacovigilance. Pharmaceutical/ life sciences companies outsource R&D works to CROs for better time management, test data maintenance, and focus on concrete results and help address the current pandemic.

While the role of CROs was not very well defined in the early 2000s, there has been a gradual evolution of CROs moving from being mere project management vendors to strategic partners for life science organizations. Contract work in various steps of the life cycle from R&D to commercialization and sponsored clinical trials have become a necessity for the research and development wings of any biotechnology or pharmaceutical company.

Active engagement with CROs has proven to help in accelerating the process while managing the details efficiently and now these Contract Research Organizations need to be prepared to streamline their project work without a process breakdown.

CROs have evolved from a target-based model to become more a strategic partner to life sciences and biotechnology companies.

For any pharmaceutical company, conducting sponsored trials to drive their products safely and quickly to the market is an important aspect of overall project success. Earlier, these projects were outsourced to CROs with a limited scope of time and budget management. However, now the CROs are expected to manage risks, apply newer tools and techniques to maintain transparency throughout the clinical trials and related processes. The Rapidly expanding industry is posing a demand on CROs to keep up with market conditions.

The global market for clinical trial services to biopharmaceutical, biotechnology, and medical device companies is forecast to grow at 12%
year on year up to 2021. Contract Research Organizations Global Market Report

This stat is quickly becoming obsolete due to the current state of affairs and the need for contract research and development services have already grown tremendously to aid the life sciences companies in their quest to find a vaccine for the pandemic.

FIGURE 1 Steps for Right Partner Selection

The growth and general technological disruptions in project management have led to a progressive change in the roles that CROs play while managing the sponsored clinical trials.

What are some of the major areas reflecting this rapid and definite evolution?

  • End-to-End Strategic Partnership: CROs are no longer just outsourced vendors for life sciences companies to carry out Pharma research, or conduct clinical trials in a stipulated amount of time. As the intricacies of the current world have already changed every aspect of project management, CROs are now expected to take complete ownership in the strategic moves of a Pharma company and transform into a strategic partner to make their clients successful. End-to-end coordination with pharmaceutical companies gives Contract Research Organizations enough time and stability to focus on core research. This aids towards capturing the right kind of clinical data to help move the drug forward to commercial markets.
  • Bringing Innovation to the Table: CRO project management is not just about completing given tasks while sticking to some fictitious timelines. The needed collaboration between CROs and their life sciences customers has increased, giving rise to a need for better project management methodologies. These Organizations now handle the ‘cradle to grave’ process of the contract research work. Pharmaceutical companies expect innovative, out-of-the-box solutions to manage risks, cut down costs, and push the boundaries of paramedical science while complying with the government’s rules and regulations. CRO project management has changed from being reactive (problem-solving) to becoming proactive (anticipating the problems and providing feasible solutions for them well in advance).

FIGURE 2 Key Parameters CROs are Assessed on

  • Being Technologically Ahead: Companies can start with 3 main technology initiatives – transitioning to cloud, strong workflows to moving processes/procedures forward, and to use online collaboration tools embedded with the overall infrastructure.

All of these above points are leading to a cumulative phenomenon of faster results, lesser errors, better team management, and overall improved communication between the client and the CRO for the entire project life cycle.

Customer Experience and Engagement

A crucial part of Project Management is to actively engage clients on various projects that require constant collaboration. Customer experience and engagement were given less importance in the past and can no longer be ignored. In order to make the strategic partnership a tactical success for both parties engaged in the contract, proper customer experience and engagement has become a crucial step in the life cycle of the project. If we were to take a 2 pronged approach on how customer experience can be handled, one is through the processes and procedures laid out in the engagement, and the other is through the slew of technologies and tools that can be used to make it a seamless experience.

Connect your processes, customer data, and tools with Dynamics 365 and the Microsoft Cloud

Customer Experience (CX) and Customer Engagement (CE) can be made better for a CRO

01.Process and Procedures

Making some minor tweaks in existing processes and procedures is needed to enhance the customer experience and engagement during a project lifecycle. Below are some of the areas to consider for better CX and CE:

  • Improving team management
  • Quick onboard of experts for clinical trials
  • Effective cost management due to tightened budgets
  • Proactive management of risks in the clinical trial process
  • Mitigation strategies of probable risks
  • Project monitoring and reporting with detailed analytics to better understand research data
  • Effective resource planning to optimize resources for multiple projects.
  • Simplify milestone-based billing
  • Improve deviation-tracking methods to remove unknowns that are notified earlier rather than later in the project lifecycle.

There is a need for a next-generation CX/ CE platform in life sciences organizations: a disruptive platform capable of replacing old generation CRM systems to accelerate development and drive demand. Microsoft Dynamics 365 is one such system that offers all tools and capabilities within one comprehensive ecosystem.

The seamless integration between Dynamics 365, robust cloud and AI offerings, and familiar tools such as Office 365 enables companies to rapidly develop a powerful, intelligent platform. It is a class-leading life science customer engagement platform that functions across mobile devices – which is a large market need.

02.Digital Advancement

This point was covered briefly in section 2 and taking it further, companies would absolutely require the below to enhance their customer experience and engagement:

  • Move from legacy systems to the cloud
  • Use advanced analytics for risk prediction and mitigation
  • Systematically manage their R&D database with digital applications
  • Improve collaboration with clients through collaboration tools
  • Reducing human intervention and semi-automate project management workflows
  • Customer self-service and supplier self-service portals to better manage the engagement from both the customer and a subcontractor’s end
  • In-line reporting through key project milestones to customer to build trust and visibility

03.The Inevitable Evolution

The evolution in the role of CRO to manage R&D through project management is leading to greater expectations by their life sciences clients. Pharmaceutical companies are looking for CROs that are not afraid to push boundaries and are adept at the latest tools and techniques. Since pharmaceutical firms are aiming for greater customer satisfaction, use of latest technologies, and overall better project management, they are engaging with CRO’s at an integral level.

This in turn is causing CROs to be more innovative and agile in their approach when it comes to project management. This interdependent relationship will not only be beneficial for clinical trials, but it will also improve the overall research and development process of a pharmaceutical company. A well-managed and organized workflow-based environment will be of great benefit to both the CRO and their life sciences customers who engage in a contract with them. Microsoft Dynamics 365 Finance and Supply Chain would make a good comprehensive system to aid a CRO to become better strategic partners to Pharma and Biotech companies.

Figure 3How to Create Successful Sourcing Partnerships?

Modernize Finance & Operations: Increase your speed of business with unified processes and predictive analytics

The speed of doing business is increasing. As companies seek to stay competitive, they must rely on technology to provide agility and the capabilities needed to excel. However, many organizations are still running on ERP systems that are complex, inflexible, and impede their ability to innovate and grow.

Microsoft Dynamics 365 F&O helps you to

  • Elevate your company’s financial performance and streamline its supply chain management
  • Innovate with connected operations in an extensible platform
  • Drive HR operational excellence through organizational agility and centralized data
  • Unify the processes listed above with predictive analytics and intelligence
  • Track and trace inventory management
  • End-to-end customer project management

Key Takeaways

  • Throughout the world, CROs are transforming from a time-bound project management role towards a more performance and results-oriented role in order to keep up with the current state of the market conditions.
  • As technology is evolving, so are the tools of project management. CROs are equipping themselves with these tools for better time management, budget management, and risk mitigation.
  • Technology that allows smoother onboarding of customers and suppliers to handle clinical trials will be a need of the hour. Pharmaceutical companies are looking for CROs who can be their end-to-end project execution partners while providing innovative solutions for seamless research and development or testing processes.
  • While time management and cost management will always be top priorities for CROs when it comes to any project, they will also need to develop adjacent digital competencies to offer more ROI for funds spent by pharmaceutical companies.

About XcelPros

XcelPros is a Chicago-based company and delivers transformation through technology. We offer business and technology solutions with deep industry experience in Chemical, Pharma, Life Sciences (including Medical Devices, Bio-Medical & Biotech), Insurance, Discrete Manufacturing, Process Manufacturing, Distribution and Food & Beverage.

XcelPros is a Microsoft Gold Partner, Direct Cloud Solutions Provider (CSP) and a Systems Integrator (SI) offering software licensing, implementation and consulting services for Microsoft Dynamics 365, CRM, Microsoft Dynamics AX, Business Intelligence & Analytics (Power BI), SharePoint, Office 365 and Azure (Cloud, IOT, Microsoft Flow amongst many others).

Our mission is to provide integrated technology solutions that amplify impact and empower our customer’s businesses. We believe technology is the key enabler of exponential growth for us and our customers.

Contact XcelPros today to transform your business.

Call us toll-free – 1.855.411.0585 (or) visit www.xcelpros.com